| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 684.01B | 787.72B | 670.82B | 614.10B | 627.61B | 594.84B |
| Gross Profit | 104.04B | 114.67B | 100.48B | 89.16B | 81.84B | 84.32B |
| EBITDA | 60.12B | 68.14B | 56.98B | 47.02B | 44.85B | 51.75B |
| Net Income | 27.52B | 31.03B | 26.86B | 20.06B | 22.23B | 27.77B |
Balance Sheet | ||||||
| Total Assets | 572.61B | 691.15B | 642.50B | 591.64B | 577.94B | 535.62B |
| Cash, Cash Equivalents and Short-Term Investments | 50.39B | 41.72B | 40.01B | 48.25B | 51.72B | 55.61B |
| Total Debt | 111.17B | 137.24B | 133.84B | 106.43B | 115.72B | 80.62B |
| Total Liabilities | 252.94B | 344.41B | 315.72B | 272.57B | 270.00B | 228.56B |
| Stockholders Equity | 314.61B | 342.13B | 321.14B | 313.21B | 303.36B | 303.56B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 23.61B | -8.92B | 24.56B | -5.87B | 8.46B |
| Operating Cash Flow | 0.00 | 33.23B | 6.84B | 41.90B | 5.48B | 26.41B |
| Investing Cash Flow | 0.00 | -14.99B | -18.43B | -13.59B | -13.33B | -20.39B |
| Financing Cash Flow | 0.00 | -16.50B | 2.89B | -30.55B | 3.30B | 5.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥631.89B | 17.42 | 8.34% | 2.66% | 2.61% | 22.78% | |
78 Outperform | ¥265.91B | 14.08 | 7.43% | 2.78% | 2.69% | -6.90% | |
78 Outperform | ¥618.48B | 15.42 | ― | 2.15% | 0.46% | 38.67% | |
72 Outperform | ¥561.78B | 18.69 | ― | 2.51% | 17.43% | 16.94% | |
70 Neutral | ¥322.85B | 14.85 | 8.70% | 2.28% | 4.11% | 37.43% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |